Search
CELL BANK Website

Back Back
RCB0778 : CW-2  update : 2018/07/06
CommentColon carcinoma. CEA-positive, nude mouse-transplantable.
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Mitsuhashi, Maki
Originator Mitsuhashi, Maki
Year of deposit 1992
Animal human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Female
Age at sampling 55 years
Tissue colon
Classification cancer
Year of origin 1990
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Virus (HIV) (-)
Isozyme LD, NP
Chromosome mode 44-92(50) : 44(1),45(5),46(42),47(1),92(1)
Images
deposit info
lot info
Reference information Reference 0
User's Publication 21


To topTop
Reference

To topTop
User's Publication
7334  Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients.  Ito H, Hasegawa K, Hasegawa Y, Nishimaki T, Hosomichi K, Kimura S, Ohba M, Yao H, Onimaru M, Inoue I, Inoue H.  Sci Rep  2015  5:10455  PubMed ID: 25994878
7414  Irinotecan induces cell cycle arrest, but not apoptosis or necrosis, in Caco-2 and CW2 colorectal cancer cell lines.  Kaku Y, Tsuchiya A, Kanno T, Nishizaki T.  Pharmacology  2015  95:154-9  PubMed ID: 25833236
7823  Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.  Matsuo T, Nishizuka SS, Ishida K, Iwaya T, Ikeda M, Wakabayashi G.  BMC Res Notes  2011  4:140  PubMed ID: 21554739
8475  Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors.  Saito M, Yaguchi T, Yasuda Y, Nakano T, Nishizaki T.  Cancer Lett.  2009  290:211-5  PubMed ID: 19822392
8943  Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice.  Sun L, Fu BB, Liu DG.  Cell Res.  2005  15:770-6  PubMed ID: 16246266
9508  HUHS1015 Suppresses Colonic Cancer Growth by Inducing Necrosis and Apoptosis in Association with Mitochondrial Damage.  Kaku Y, Tsuchiya A, Shimizu T, Tanaka A, Nishizaki T.  Anticancer Res.  2016  36:39-48  PubMed ID: 26722026
9823  Overcoming resistance to HER2 inhibitors through state-specific kinase binding.  Novotny CJ, Pollari S, Park JH, Lemmon MA, Shen W, Shokat KM.  Nat. Chem. Biol.  2016  12:923-930  PubMed ID: 27595329
10398  RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer.  Matsushita N, Yamamoto S, Inoue Y, Aruga A, Yamamoto M.  Oncol Lett  2017  14:2281-2287  PubMed ID: 28789449
10498  Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.  Inaguma S, Lasota J, Felisiak-Golabek A, Kowalik A, Wang Z, Zieba S, Kalisz J, Ikeda H, Miettinen M.  J Pathol Clin Res  2017  3:268-278  PubMed ID: 29085667
11364  Urate Transport via Paracellular Route across Epithelial Cells.  Kimura T, Tsukada A, Fukutomi T, Ichida K, Ohtsuki S, Sakurai H.  Biol. Pharm. Bull.  2019    PubMed ID: 30606989
3752  Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver.  Kataoka H, Uchino H, Asada Y, Hatakeyama K, Nabeshima K, Sumiyoshi A, Koono M.  Int J Cancer  1997  72(5):878-84  PubMed ID: 9311608
3754  Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells.  Nabeshima K, Shimao Y, Inoue T, Itoh H, Kataoka H, Koono M.  Int J Cancer  1998  78(6):750-9  PubMed ID: 9833769
3755  Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa.  Kataoka H, Uchino H, Denda K, Kitamura N, Itoh H, Tsubouchi H, Nabeshima K, Koono M.  Cancer Lett  1998  19;128(2):219-27  PubMed ID: 9683286
3762  Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas.  Kataoka H, Itoh H, Uchino H, Hamasuna R, Kitamura N, Nabeshima K, Koono M.  Cancer Lett  2000  148(2):127-34  PubMed ID: 10695988
5882  Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.  Shichiri M, Fukai N, Kono Y, Tanaka Y.  Cancer Res  2009  69(11):4760-8  PubMed ID: 19458074
6316  Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.  Miyaki Y, Suzuki K, Koizumi K, Kato T, Saito M, Kamiyama H, Maeda T, Shibata K, Shiya N, Konishi F.  Int J Oncol  2012  40(1):217-26  PubMed ID: 21901246
6317  Array-based identification of common DNA methylation alterations in ulcerative colitis.  Koizumi K, Alonso S, Miyaki Y, Okada S, Ogura H, Shiiya N, Konishi F, Taya T, Perucho M, Suzuki K.  Int J Oncol  2012  40(4):983-94  PubMed ID: 22159500
9428  Bombyx mori silk fibroin membranes as potential substrata for epithelial constructs used in the management of ocular surface disorders.  Chirila T, Barnard Z, Zainuddin, Harkin DG, Schwab IR, Hirst L.  Tissue Eng Part A  2008  14(7):1203-11  PubMed ID: 18380593
11553  Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.  Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H.  Mol Ther Oncolytics  2019    PubMed ID: 31193737
11832  Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.  Robichaux JP, Elamin YY, Vijayan RSK, Nilsson MB, Hu L, He J, Zhang F, Pisegna M, Poteete A, Sun H, Li S, Chen T, Han H, Negrao MV, Ahnert JR, Diao L, Wang J, Le X, Meric-Bernstam F, Routbort M, Roeck B, Yang Z, Raymond VM, Lanman RB, Frampton GM, Miller VA, Schrock AB, Albacker LA, Wong KK, Cross JB, Heymach JV.  Cancer Cell  2019    PubMed ID: 31588020
6410  Is parainfluenza virus a threatening virus for human cancer cell lines?  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309



Back Back Return Top Page